Does VERTEPORFIN Cause Polypoidal choroidal vasculopathy? 128 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Polypoidal choroidal vasculopathy have been filed in association with VERTEPORFIN (Visudyne). This represents 17.0% of all adverse event reports for VERTEPORFIN.
128
Reports of Polypoidal choroidal vasculopathy with VERTEPORFIN
17.0%
of all VERTEPORFIN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Polypoidal choroidal vasculopathy From VERTEPORFIN?
Of the 128 reports, 5 (3.9%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Polypoidal choroidal vasculopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VERTEPORFIN. However, 128 reports have been filed with the FAERS database.
What Other Side Effects Does VERTEPORFIN Cause?
Visual acuity reduced (173)
Off label use (129)
Disease progression (115)
Age-related macular degeneration (90)
Retinal haemorrhage (70)
Product use in unapproved indication (57)
Choroidal neovascularisation (47)
Retinal detachment (42)
Subretinal fluid (42)
Detachment of retinal pigment epithelium (36)
What Other Drugs Cause Polypoidal choroidal vasculopathy?
Which VERTEPORFIN Alternatives Have Lower Polypoidal choroidal vasculopathy Risk?
VERTEPORFIN vs VESICARE
VERTEPORFIN vs VFEND
VERTEPORFIN vs VIAGRA
VERTEPORFIN vs VIBEGRON
VERTEPORFIN vs VICODIN